Featured Research

from universities, journals, and other organizations

Lucent Technologies Announces Industry's First All-Optical Cross Connect

Date:
May 8, 1997
Source:
Bell Labs - Lucent Technologies
Summary:
Lucent Technologies all-optical cross connect reconfigures networks photonically

Lucent Technologies announces industry's first All-Optical Cross Connect

Related Articles


FOR RELEASE: TUESDAY, MAY 06, 1997

MURRAY HILL, N.J. -- Lucent Technologies announced today the industry's first All-Optical Cross Connect that delivers quicker recovery from service interruptions, significant savings in operating costs, higher reliability and greater administrative flexibility.

The Optical Cross Connect allows service providers to efficiently move wavelengths from point to point in their network without making unnecessary and costly conversions along the way. Managing wavelengths at the optical level is less costly than dropping down to the electrical level because the cost of the electrical devices is eliminated. In addition reliability is increased and operations costs are decreased because fewer network elements such as back-to-back terminals are required.

The Optical Cross Connect also provides the important service restoration capabilities found in today's Synchronous Optical Networking (SONET) layer. In particular, in the event of catastrophic failures, services can be restored at the wavelength level using an Optical Cross-Connect, potentially delivering much faster restoration than today's electrical restoration schemes.

"The idea of an all-optical network and its promise of cost effective unlimited bandwidth has been a concept found only in research papers and labs - until now, " said Richard Moscioni, SONET Business Management Vice President. "Deploying an all-optical network takes more than just technology or more wavelengths. Dense Wavelength Division Multiplexing is just the ticket to entry for optical networking. Service providers are demanding a level of network expertise in their vendors that includes total network solutions. Lucent Technologies is uniquely positioned to provide this complete package to our customers."

The Optical Cross Connect continues the migration to an all-optical network that Lucent began in 1995 with the introduction of its Optical Line System - Lucent's Dense Wavelength Division Multiplexing (DWDM) product. Lucent Technologies is the worldwide leader in optical networking with thousands of amplifiers and hundreds of systems shipped to customers worldwide.

The Optical Cross Connect will be demonstrated at Lucent Technologies' booth #3549 at SuperComm '97 in New Orleans from June 3-5. Lucent's SONET Business Group demonstration at SuperComm '97 will focus on three areas: Bell Lab's Innovations; Optical Networking Solutions (including the Optical Cross Connect); seamlessly integrating embedded SONET systems to deliver all services (Voice, Data and Video) over one network.

The Optical Cross Connect builds upon Lucent's long-standing research efforts on DWDM and optical networking including Lucent's participation in the Multiwavelength Optical Networking (MONET) Consortium.

The Optical Cross Connect will be available in limited production in third quarter '97. Lucent will be working closely with customers to determine features and functionality for future releases.

Lucent Technologies designs, builds, and delivers a wide range of public and private networks, communications systems and software, consumer and business telephone systems and microelectronics components. Bell Laboratories is the research and development arm of the company. More information about Lucent Technologies, headquartered at Murray Hill, N.J., is available at http://www.lucent.com.

For more information, reporters may contact:

Kabby Hong 303-290-2641 (work) 303-779-0977 (home) Email:khong@lucent.com

Jane Moulton 908-582-7658 (work) 201-763-7017 (home) Email:jmoulton@lucent.com


Story Source:

The above story is based on materials provided by Bell Labs - Lucent Technologies. Note: Materials may be edited for content and length.


Cite This Page:

Bell Labs - Lucent Technologies. "Lucent Technologies Announces Industry's First All-Optical Cross Connect." ScienceDaily. ScienceDaily, 8 May 1997. <www.sciencedaily.com/releases/1997/05/970508195941.htm>.
Bell Labs - Lucent Technologies. (1997, May 8). Lucent Technologies Announces Industry's First All-Optical Cross Connect. ScienceDaily. Retrieved March 6, 2015 from www.sciencedaily.com/releases/1997/05/970508195941.htm
Bell Labs - Lucent Technologies. "Lucent Technologies Announces Industry's First All-Optical Cross Connect." ScienceDaily. www.sciencedaily.com/releases/1997/05/970508195941.htm (accessed March 6, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, March 6, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Bupa Eyes India Healthcare Opportunities

Bupa Eyes India Healthcare Opportunities

Reuters - Business Video Online (Mar. 5, 2015) Bupa is hoping to expand in India&apos;s fast-growing health insurance market, once a rule change on foreign investment is implemented. The British private healthcare group&apos;s CEO tells Grace Pascoe why it&apos;s so keen on the new opportunity. Video provided by Reuters
Powered by NewsLook.com
Liberia Releases Last Ebola Patient, But Threat Remains

Liberia Releases Last Ebola Patient, But Threat Remains

Newsy (Mar. 5, 2015) Liberia&apos;s last Ebola patient has been released, and the country hasn&apos;t recorded a new case in a week. However, fears of another outbreak still exist. Video provided by Newsy
Powered by NewsLook.com
Doctor in Your Pocket Is Getting Smarter

Doctor in Your Pocket Is Getting Smarter

Reuters - Business Video Online (Mar. 5, 2015) Mobile apps are turning smartphones into a personal doctors, with users able to measure heart rate, blood pressure and even blood sugar. But will it change our behaviour? Ivor Bennett reports from the Mobile World Congress in Barcelona. Video provided by Reuters
Powered by NewsLook.com
AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

Newsy (Mar. 5, 2015) AbbVie announced Wednesday it will buy cancer drugmaker Pharmacyclics in a $21 billion deal. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins